Page 6 - Epic Sciences News Today

Dublin, June 08, 2022 (GLOBE NEWSWIRE) -- The "Market Forecasts for Immuno-Oncology Diagnostics, Including Executive/Consultant Guides and Customized...

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

/PRNewswire/ -- Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F...

/PRNewswire/ -- Epic Sciences, Inc. ("Epic" or "Epic Sciences"), a privately held diagnostics company, has completed a $43 million first close of its Series F...

FREMONT, Calif., May 26, 2022 /PRNewswire/ -- The global liquid biopsy market is projected to reach $19.06 billion in terms of revenue by 2032 at a CAGR of 19.83%, reveals the premium market

DUBLIN--(BUSINESS WIRE)--The "Circulating Tumor Cell Market Research Report by Specimen (Blood, Bone Marrow, and Other Body Fluids), Technology, Product, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering. The Global Circulating Tumor…

The "Circulating Tumor Cell Market Research Report by Specimen (Blood, Bone Marrow, and Other Body Fluids), Technology, Product, Application, Region (Americas, Asia-Pacific, and Europe, Middle East Africa)

/PRNewswire/ -- Epic Sciences, Inc. has added DefineMBC™, a novel comprehensive blood-based test for characterizing metastatic breast cancer, to its CLIA...

/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leader in advanced cancer diagnostics, today announced that the company generated revenue of $486.6...

/PRNewswire/ -- The "Genetic Testing. Global Market Forecasts for Applications and Technologies. Updated for COVID-19 Pandemic impact With Executive and...